AFC
TWST icon

Ares Financial Consulting’s Twist Bioscience TWST Stock Holding History

Ares Financial Consulting’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1K Hold
497
– – 0.04% 226
2026
Q1 		$24.6K Buy
+497
New +$22.3K 0.02% 349

Other funds holding TWST

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Ares Financial Consulting's TWST Position: Q2 2026 in Review

Ares Financial Consulting held its Twist Bioscience (TWST) position steady in Q2 2026 at 497 shares worth $51.1K. The position accounts for 0.04% of the portfolio, ranked #226.

Ares Financial Consulting first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Ares Financial Consulting held 497 shares of Twist Bioscience worth $51.1K as of Q2 2026.
  • Ares Financial Consulting left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.04% of Ares Financial Consulting's portfolio in Q2 2026, its #226 holding.
  • Ares Financial Consulting first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.